COVID-19 (N = 110) | CKD patients (N = 33) | Healthy subjects (N = 35) | P (K-W) | ||||
---|---|---|---|---|---|---|---|
Median | IQR 25–75% | Median | IQR 25–75% | Median | IQR 25–75% | ||
Age (years) | 60 | 50–69 | 55 | 44.5–58 | 50 | 39–57 | < 0.001a |
BMI1 (kg/m2) | 28 | 24.6–31.6 | 25.0 | 23.5–28.0 | 24 | 22–27 | < 0.001b |
Creatinine (µmol/l) | 73 | 57.5–89 | 122 | 107–160 | 72 | 66–77 | < 0.001c |
eGFR2 (ml/min/1.73m2) | 84 | 67–90 | 53 | 40–65 | 102 | 96–108 | < 0.001d |
CRP3 (mg/l) | 99 | 63–174 | 1.6 | 0.9–4.3 | 0.89 | 0.31–2.2 | < 0.001e |
B cell modulation | |||||||
BAFF4 (pg/ml) | 824 | 576–1099 | 448 | 395–551 | 403 | 365–449 | < 0.001f |
IL-45 (pg/ml) | 104 | 88–124 | 134 | 111–208 | 119 | 98–156 | < 0.001 g |
IFN-α6 (pg/ml) | 18.5 | 9–36.5 | 10 | 4.5–25 | 8 | 5–32.5 | 0.02 h |
T cell modulation | |||||||
sCD257/IL-2Rα8 (pg/ml) | 1178 | 931–1587 | 734 | 582–808 | 363 | 309–441 | < 0.001i |
sCD40L (pg/ml) | 1515 | 1220–1884 | 7663 | 5688–9955 | 7239 | 4985–9564 | < 0.001j |
sPD-L19 (pg/ml) | 146 | 96–227 | 83 | 61–102 | 39 | 30–48 | < 0.001 k |
sCD95/Fas (pg/ml) | 6083 | 4727–7292 | 8519 | 7373–10,112 | 5572 | 4917–6058 | < 0.001 l |